Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Gladding

Christopher J. Gladding, Danville, CA US

Patent application numberDescriptionPublished
20100054286Semiconductor Diode Pumped Laser Using Heating-Only Power Stabilization - A laser system such as a DPSS green laser uses a laser diode pump source that is specially selected so that the wavelength of diode source is centered around the optimal source wavelength, typically 808 nm, which produces the optimal green laser output from the system. Unlike prior systems in which the source wavelength is at 808 nm at typical ambient temperature of about 25° C., in the system disclosed, the source wavelength is at 808 nm at a temperature significantly higher than ambient, which may be as high as about 40° C. In this system optimum performance can be established and maintained in a broad temperature range such as 0˜50° C. using only a heating element adjacent to the diode laser pump source. No cooling is required. Cost, size, and power requirements of the system are therefore minimized.03-04-2010

Derek Gladding, San Francisco, CA US

Patent application numberDescriptionPublished
20110208946Dual Mode Floating Point Multiply Accumulate Unit - Disclosed are various embodiments of a stream processing unit for single instruction multiple data (SIMD) processing, wherein the stream processing unit executes a stage of a Multiply-Accumulate calculation. In one embodiment, the stream processing unit comprises a plurality of scalar arithmetic logic units (ALUs) configured to receive data having a plurality of data types. The number and type of scalar ALUs corresponds to an SIMD factor. In one embodiment, the scalar ALUs are executed sequentially with a delay being introduced in between execution of each of the scalar ALUs, wherein the delay corresponds to the SIMD factor.08-25-2011

Patrick Gladding, Auckland NZ

Patent application numberDescriptionPublished
20110045481METHODS AND COMPOSITIONS FOR THE ASSESSMENT OF DRUG RESPONSE - The present invention provides methods for predicting or determining a subject's response to an antiplatelet agent, and methods for determining a subject's suitability to a treatment regime or intervention for a disease associated with platelet aggregation, using analysis of genetic polymorphisms. The present invention also relates to the use of genetic polymorphisms in assessing a subject's response to an antiplatelet agent. Nucleotide probes and primers, kits, and microarrays suitable for such assessment are also provided.02-24-2011

Patrick A. Gladding, Cleveland, OH US

Patent application numberDescriptionPublished
20110060532METHODS AND COMPOSITIONS FOR THE ASSESSMENT OF DRUG RESPONSE - The present invention provides methods for predicting or determining a subject's response to an antiplatelet agent, and methods for determining a subject's suitability to a treatment regime or intervention for a disease associated with platelet aggregation, using analysis of genetic polymorphisms. The present invention also relates to the use of genetic polymorphisms in assessing a subject's response to an antiplatelet agent. Nucleotide probes and primers, kits, and microarrays suitable for such assessment are also provided03-10-2011